More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...

Regeneron Pharmaceuticals said on Monday a combination of its experimental drug and Novo Nordisk's obesity drug Wegovy helped ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...

Ozempic, which was introduced into the UK in January 2019, having previously been approved in the US in 2017, is an ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...